Connect with us

International

Studies show monkeys have low chances of reinfection from COVID-19

Published

on

Two new studies conducted on monkeys have proven that the animals are less likely to be reinfected by COVID-19.

The studies further validate the assumption that surviving COVID-19 may result in immunity from reinfection and that vaccines under development may succeed, US researchers said on Wednesday.

In the first study, nine monkeys were infected with COVID-19.

After they recovered, they were exposed to the virus and failed to fall sick again.

They “do develop natural immunity that protects against re-exposure,” said Dr. Dan Barouch, a researcher at the Center for Virology and Vaccine Research at Harvard’s Beth Israel Deaconness Medical Center in Boston.

In a second study, Barouch tested six prototype vaccines on 25 monkeys and exposed them to 10 other control animals infected with SARS-CoV-2.

The control animals were discovered to show high degree of the virus in their lungs and noses while the vaccinated animals manifested “a substantial degree of protection”, eight of which were completely protected, Barouch said.

READ ALSO: Collapsed dam floods Michigan town, displaces many

“It’s very good news,” Barouch noted.

“These data will be seen as a welcome scientific advance,” he added.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now